The Global Calcium Phosphate Bone Cement Market Size accounted for USD 797.6 Million in 2023 and is estimated to achieve a market size of USD 1,303.1 Million by 2032 growing at a CAGR of 5.7% from 2024 to 2032.

Calcium Phosphate Bone Cement Market Highlights

• The global calcium phosphate bone cement market is projected to reach USD 1,303.1 Million by 2032, with a CAGR of 5.7% from 2024 to 2032
• In 2023, the North American calcium phosphate bone cement market held a value of approximately USD 279.2 million
• The Asia-Pacific region is expected to grow at a CAGR of over 6.4% from 2024 to 2032
• Antibiotic-loaded bone cement type dominates and holds 64% of share in 2023
• Increasing research on bioactive and injectable material for enhanced bone regeneration is the calcium phosphate bone cement market trend that fuels the industry demand

Calcium phosphate bone cement (CPC) is a biocompatible, moldable substance used in orthopedic and dentistry procedures to repair bone abnormalities. It resembles the mineral composition of real bone, encouraging bone regeneration and integration. CPC is often used to fill bone gaps, stabilize fractures, and support implants. It solidifies in place, providing structural support before eventually being resorbed and replaced by new bone tissue. Its biocompatibility and ability to conform to various shapes make it useful for minimally invasive operations.

Global Calcium Phosphate Bone Cement Market Dynamics

Market Drivers

• Growing demand for minimally invasive surgical procedures
• Increasing prevalence of orthopedic disorders and bone injuries
• Advancements in biomaterial technology enhancing product performance

Market Restraints

• High cost of advanced bone cement formulations
• Limited mechanical strength compared to traditional bone grafts
• Stringent regulatory approvals for medical devices

Market Opportunities

• Rising geriatric population prone to osteoporosis and fractures
• Expanding applications in dental and craniofacial surgeries
• Emerging markets with increasing healthcare infrastructure investments

Calcium Phosphate Bone Cement Market Report Coverage

Calcium Phosphate Bone Cement Market Insights

Patients and surgeons increasingly prefer minimally invasive procedures because of faster recovery times, less pain, and shorter hospital stays. Key manufacturers are also partnering to develop minimally invasive technologies in new markets. For example, in February 2023, Encision Inc. entered into a Proof of Concept Services Agreement with Vicarious Surgical Inc. The Vicarious surgical robot design aims to improve instrument precision, control, and visualization in robotically assisted minimally invasive surgery. In December 2022, Abbott also announced the launch of minimally invasive devices, TAVI, for heart valve therapy in India. These advancements by leading manufacturers are fuelling demand for calcium phosphate bone cement market.

Osteoporosis, fractures, and joint-related illnesses are becoming more common as the population ages and lifestyle factors change. For example, according to the National Institutes of Health (NIH), osteoporosis is the leading cause of fractures in postmenopausal women and older men. Osteoporosis is most prevalent among non-Hispanic white and Asian women. Non-Hispanic white men are more likely to develop osteoporosis. Some children and teenagers acquire an uncommon kind of idiopathic juvenile osteoporosis. The rise in bone-related health issues has increased the demand for effective bone repair materials such as calcium phosphate bone cement.

The creation of high-quality, bioactive calcium phosphate bone cement necessitates sophisticated manufacturing procedures and costly raw materials. This results in increased prices, which may limit its adoption, particularly in cost-sensitive countries.

The global growth in senior populations, who are more prone to bone density loss and fractures, is driving up demand for bone restoration options. According to the Asian Development Bank, the number of persons aged 60 and older in developing Asia and the Pacific would nearly treble by 2050, reaching 1.2 billion. Calcium phosphate bone cement's biocompatibility and bone regeneration capabilities make it a popular choice for addressing age-related concerns, which have created an opportunity for the burgeoning business.

Calcium Phosphate Bone Cement Market Segmentation

The worldwide market for calcium phosphate bone cement is split based on type, application, end-user, and geography.

Calcium Phosphate Bone Cement Market By Type

• Antibiotic-Loaded Bone Cement
• Non-Antibiotic-Loaded Bone Cement

According to the calcium phosphate bone cement industry analysis, antibiotic-loaded bone cement dominates, particularly in infection-prone surgical operations that require localized antibiotic delivery. It is especially effective in revision operations and joint replacements since it reduces post-surgical infections, improving patient outcomes. Non-antibiotic-loaded bone cement is quickly expanding in the business due to its use in common orthopedic and dental operations, which eliminates the possibility of antibiotic resistance. Its low cost and suitability for individuals who are not concerned about infection make it a rapidly increasing part of the calsium phosphate bone cement market.

Calcium Phosphate Bone Cement Market By Application

• Orthopedic Surgery
  • Trauma & Fracture Repair
  • Spinal Fusion
  • Joint Reconstruction
• Dental Applications
  • Bone Grafting
  • Dental Implants
• Craniofacial Surgery
• Vertebroplasty & Kyphoplasty
• Others

Orthopedic surgery is the leading application in the calcium phosphate bone cement market. Orthopedic surgery is also anticipated to show notable growth in market, because of the increasing prevalence of bone injuries and degenerative joint illnesses. Trauma and fracture repair and joint reconstruction are notabaly increasing the market revenue throughout the forecast period 2024 to 2032. Its capacity to offer structural support, facilitate bone healing, and adapt to diverse fracture geometries renders it indispensable in orthopedic operations. Its usage in spinal fusion for increased vertebral stability contributing to its leadership in this market. Dental applications such as bone grafting and dental implants are expanding as aesthetic dentistry and periodontal disease therapies become more prevalent. Similarly, the biocompatibility and simplicity of molding of calcium phosphate bone cement help with bone regeneration and structural integrity in craniofacial surgery, vertebroplasty, and kyphoplasty procedures.

Calcium Phosphate Bone Cement Market By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Research & Academic Institutions

According to the calcium phosphate bone cement market forecast, hospitals are the key end users, owing to the high amount of orthopedic procedures and trauma cases they handle. Their modern infrastructure and access to qualified medical professionals make them the ideal location for complex bone cement treatments. Ambulatory surgical centers (ASCs) and specialized clinics both contribute to market demand, albeit to a smaller amount than hospitals. Research and academic institutions are largely concerned with the development and study of novel applications, and so account for a lesser market share.

Calcium Phosphate Bone Cement Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of LATAM

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Calcium Phosphate Bone Cement Market Regional Analysis

North America leads the calcium phosphate bone cement market due to the presence of advanced healthcare infrastructure, high healthcare spending, and early adoption of cutting-edge medical technology. The presence of key market players, as well as intensive research and development activities, contribute to market growth. For example, Mayo Clinic orthopedic doctors are well-known both nationally and internationally for their surgical technical expertise and innovative treatments to both simple and difficult orthopedic problems. From diagnosis to treatment, Mayo Clinic orthopedic doctors on campuses in Minnesota, Arizona, and Florida are at the forefront of leveraging cutting-edge technology to drive market growth in North America.

The calcium phosphate bone cement market in Asia-Pacific is expanding rapidly due to rising healthcare investments, increased knowledge of advanced medical treatments, and a growing elderly population. According to Welcome to the United Nations (World Population Ageing 2023), population ageing is more advanced in Bangladesh and in its early stages in Rwanda and Angola. Furthermore, the increased prevalence of orthopedic injuries and dental difficulties, combined with medical tourism, is pushing demand for low-cost bone restoration options.

Calcium Phosphate Bone Cement Market Players

Some of the top calcium phosphate bone cement companies offered in our report Cardinal Health, Heraeus Medical, Stryker, Arthrex, TEKNIMED, DJO Global, Zimmer Biomet, Exactech, Trimph, DePuy Synthes, CryoLife, and Smith & Nephew.

TABLE OF CONTENT